PwC Analysis Projects Reproductive Health Market to Hit $45B by 2030 as Capital Diversifies22. September 2026
Health Guardant buys MetaSight for $59M upfront to acquire blood test techHealthradar23. Februar 2026 By the numbers Q4 revenue: $281.3 million 39% increase year over year 2025 revenue: $982 million 33% increase year…
